Health and Science

Ex-FDA chief Scott Gottlieb says he is 'skeptical' that vaping nicotine causes lung cancer

Key Points
  • "I'm skeptical that nicotine causes cancer," Gottlieb says. "It might be a tumor promoter," he acknowledges. "But it doesn't cause cancer."
  • The former FDA commissioner was reacting to a New York University study claiming that vaping nicotine causes lung cancer in mice.
  • However, Gottlieb acknowledges that he would expect inhaling e-cigarette vapor to cause damage to the lungs.
VIDEO10:1010:10
Why Scott Gottlieb is calling on the federal government to regulate marijuana

Former FDA Commissioner Scott Gottlieb told CNBC he isn't convinced that vaping nicotine is carcinogenic, calling out a study that pointed toward the opposite conclusion.

"I'm skeptical that nicotine causes cancer," Gottlieb, a trained physician, said Monday on "Squawk Box." "It might be a tumor promoter, [researchers] have said that there's a potential that nicotine is a tumor promoter, but it doesn't cause cancer."

Gottlieb was reacting to a New York University study released last week that said e-cigarette vapor with nicotine causes lung cancer and possibly bladder cancer in mice, damaging their DNA. The researchers concluded that vaping is likely "very harmful" to humans as well.

Out of 40 mice exposed in the study to e-cigarette vapor with nicotine over 54 weeks, 22.5% developed lung cancer and 57.5% developed precancerous lesions on the bladder. None of the 20 mice exposed to e-cigarette vaper without nicotine developed cancer over the four years they studied the mice, the researchers said.

Gottlieb expressed doubt, saying the study was conducted on a small scale and isolated the effects of nicotine. A spokesman for NYU said he didn't want to comment on Gottlieb's remarks, and pointed CNBC to the study's findings.

However, Gottlieb still said he would expect inhaling vapor to cause damage to the lungs.

"That said, we had a signal when I was at the FDA of damage that vaping was causing to the lungs in an animal study," said Gottlieb, a Pfizer board member who is also a CNBC contributor. The results should be out soon on the FDA study, he said. "You can't inhale something into the lungs that way on a repeated basis and not cause some damage to the lung."

Gottlieb left the FDA in April.

The research into vaping comes at a time of increased scrutiny of e-cigarettes as underage use rises and U.S. health officials trace an outbreak of a deadly lung disease linked to vaping, mostly THC, the active compound in marijuana. According to the CDC, some of the roughly 1,300 victims who have fallen ill, including at least 26 who have died, reported using only nicotine, leading doctors to say they can't rule anything out.

E-cigarette makers marketed themselves as a safer alternative to smoking regular, combustible cigarettes that can help adult smokers kick the habit.